Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 29, 2019 20:00 ET | Source: Telix Pharmaceuticals Limited

Telixが日本で腎臓がん用画像診断薬の臨床治験を開始

メルボルン, オーストラリアおよび京都, 日本, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals...
August 29, 2019 20:00 ET | Source: Telix Pharmaceuticals Limited

Telix Pharmaceuticals to Launch Japanese Renal Cancer Imaging Study

MELBOURNE, Australia and KYOTO, Japan, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the...
November 28, 2018 18:17 ET | Source: Telix Pharmaceuticals Limited

テリックスと日本メジフィジックスがアクチニウム標識腎癌治療薬の開発を目指した技術提携契約を締結

MELBOURNE, Australia, KYOTO, Japan and TOKYO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited（本社：オーストラリアメルボルン、CEO：Dr. Christian...
November 28, 2018 18:17 ET | Source: Telix Pharmaceuticals Limited

Telix and Nihon Medi-Physics to Collaborate on Actinium Renal Cancer Therapeutics

MELBOURNE, Australia, KYOTO, Japan and TOKYO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused...
August 15, 2018 19:00 ET | Source: Telix Pharmaceuticals Limited; Nihon Medi-Physics Co., Ltd.

Telix and Nihon Medi-Physics to Collaborate on Renal Cancer Imaging for the Japanese Market

MELBOURNE, Australia and KYOTO, Japan and TOKYO, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company...